It was found that adding NB-UVB light therapy to ruxolitinib (Opzelura) 1.5% cream helped many vitiligo patients who did not respond early to treatment achieve faster and more noticeable skin ...

Vitiligo is a long-term skin condition where certain areas lose their natural color and turn noticeably lighter than the ...

A controversial new treatment for vitiligo that can restore pigment to the skin might soon be offered by the NHS if it gets approved by UK health experts. Vitiligo is a condition that causes the skin ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Data served as basis for recent FDA approval of ruxolitinib cream (Opzelura™) 1.5% for the topical treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older ...

A pair of posters presented at the American Academy of Dermatology 2023 Annual Meeting showed the efficacy of ruxolitinib cream in improving symptoms of vitiligo on the face, both as assessed by ...

A year after celebrating the approval of the first treatment for repigmentation of vitiligo, dermatologists describe how ruxolitinib cream (Opzelura) has advanced the outlook for patients with the ...

- Treatment with ruxolitinib cream (Opzelura™) resulted in facial repigmentation at Week 24, characterized by a significant proportion of patients achieving ≥75% improvement from baseline in the ...

The FDA approval of topical ruxolitinib 1.5% cream changed the game for vitiligo treatment in both adult and pediatric patients, said Raj Chovatiya, MD, PhD, assistant professor of dermatology at ...

Phase 3 data supporting the approval show treatment with Opzelura resulted in improvements in facial and total body repigmentation Fifty-two week data demonstrate continued improvements in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Four of 589 adverse events were serious and included ...

I’ve been a vitiligo researcher for almost 20 years. While it affects people of all races and ethnicities equally, it’s more visible in people with darker skin tones. As a result, they may be more ...